ABILITY BIOLOGICS A
DEAD

Serial Number

98657906

Owner

ABILITY BIOLOGICS INC

Attorney

Max Vern

Filing Date

Jul 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ABILITY BIOLOGICS A Trademark

Serial Number: 98657906

ABILITY BIOLOGICS A is a trademark filed by ABILITY BIOLOGICS INC on July 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ABILITY BIOLOGICS INC (3 trademarks)

400-3 Place Ville-Marie
Montreal, Quebec H3B2E3 , CA

Entity Type: 03

Trademark Details

Filing Date

July 19, 2024

Registration Date

Not Registered

Goods & Services

antibody products and molecules acting as immune modulators for scientific and medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories;

antibody products and molecules for scientific and medical purposes;

antibody profiling for scientific research purposes, for discovery and development of new biotherapeutics; operation of scientific database and website regarding research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development; clinical trials; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] for analyzing molecular and clinical data to develop antibodies against immune targets; analysis in the field of molecular biology; molecular analysis and product optimization for the purpose of pharmaceutical development;

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 10, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 10, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2025 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2025 DOCK
ASSIGNED TO EXAMINER
Feb 11, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 10, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2025 NWOS
NEW APPLICATION ENTERED
Jul 19, 2024 NWAP